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Background: Depression and anxiety are common and independent outcome predictors
in patients with chronic heart failure (CHF). However, it is unclear whether CHF causes
depression. Thus, we investigated whether mice develop anxiety- and depression-like
behavior after induction of ischemic CHF by myocardial infarction (MI).
Methods and Results: In order to assess depression-like behavior, anhedonia was
investigated by repeatedly testing sucrose preference for 8 weeks after coronary artery
ligation or sham operation. Mice with large MI and increased left ventricular dimensions on
echocardiography (termed CHF mice) showed reduced preference for sucrose, indicating
depression-like behavior. 6 weeks after MI, mice were tested for exploratory activity,
anxiety-like behavior and cognitive function using the elevated plus maze (EPM), light-dark
box (LDB), open field (OF), and object recognition (OR) tests. In the EPM and OF,
CHF mice exhibited diminished exploratory behavior and motivation despite similar
movement capability. In the OR, CHF mice had reduced preference for novelty and
impaired short-term memory. On histology, CHF mice had unaltered overall cerebral
morphology. However, analysis of gene expression by RNA-sequencing in prefrontal
cortical, hippocampal, and left ventricular tissue revealed changes in genes related to
inflammation and cofactors of neuronal signal transduction in CHF mice, with Nr4a1 being
dysregulated both in prefrontal cortex and myocardium after MI.
Conclusions: After induction of ischemic CHF, mice exhibited anhedonic behavior,
decreased exploratory activity and interest in novelty, and cognitive impairment. Thus,
ischemic CHF leads to distinct behavioral changes in mice analogous to symptoms
observed in humans with CHF and comorbid depression.
Keywords: chronic heart failure, myocardial infarction, anxiety, depression, mice
INTRODUCTION
Major depression and anxiety disorders are common comor-
bidities in patients with chronic heart failure (CHF). In the
Würzburg heart failure registry (INH registry) approximately
18% of the patients suffered from severe depression (Faller et al.,
2009; Angermann et al., 2011), which occurs to happen 3–5 times
more often in patients with CHF than in the general population,
depending on the severity of CHF symptoms and co-morbidities
(Ayuso-Mateos et al., 2001; Rutledge et al., 2006). Major depres-
sion is an independent predictor of mortality in CHF patients
(Jiang et al., 2004). Remission of depression may improve prog-
nosis of CHF (Jiang et al., 2011). Hospitalization and severe
CHF symptoms are recognized as independent predictors of
incident depression (Freedland et al., 2003; Lossnitzer et al.,
2013). However, the mechanisms of interaction between CHF
and the central nervous system are unclear. In humans, this
interdependence is complex and influenced by psychosocial and
professional impairment (Luttik et al., 2005).
Presently, it is still unclear whether experimental CHF
leads to depression-like behavior. A few experimental stud-
ies reported behavioral consequences after acute myocardial
infarction (MI) (Schoemaker and Smits, 1994; Wann et al.,
2007, 2009; Bah et al., 2011). Schoemaker and Smits found
increased anxiety-like behavior, diminished interest in a new
environment, reduced overall mobility and avoidance of social
interaction in rats up to 4 weeks after MI (Schoemaker and
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Smits, 1994). Wann et al. described depression-like behav-
ior in rats 2 weeks after ligation of the left coronary
artery, including anhedonia (i.e., decreased sucrose intake) and
behavioral despair (i.e., increased immobility in the forced
swim test); both could be reversed by antidepressant treat-
ment (Wann et al., 2007, 2009; Bah et al., 2011). However,
these studies lack long term observation and might have
been confounded by post-traumatic stress after operation and
acute MI.
CHF develops in mice as a function of MI size and time
after MI (Hofmann et al., 2012). Functional changes have been
reported in brain nuclei of rats with experimental CHF (Hu et al.,
2001) and in humans (Almeida et al., 2012). However, the mech-
anisms and potential systemic consequences, as well as structural
or molecular changes in the brain due to CHF are unknown.
Moreover, no studies in mice were conducted so far and studies
in mice would allow a more feasible genetic manipulation than in
rats.
Therefore, we investigated long-term behavioral effects of
CHF in mice after MI. We intended to specifically test behav-
ioral and cognitive changes known to be altered in patients with
CHF, i.e., depression, motivational deficits, short-term memory
impairment. Behavioral tests were selected based on their valid-
ity regarding anxiety- and depression-like behavior as well as
exploratory behavior and locomotor activity in mice: (1) The
sucrose preference test (SPT) as a model for anhedonia, (2) ele-
vated plus maze (EPM), (3) light-dark box (LDB), (4) open field
(OF), and (5) object recognition (OR) tests. In these exploration-
based tasks, the mouse’s innate drive to approach is in conflict
with avoidance of a potential threat (Cryan and Holmes, 2005).
Mice are expected to avoid aversive areas in the apparatus such
as an open, elevated arm (EPM), a brightly lit compartment
(LDB) and the center area of a novel, brightly lit open field
(OF). Taken together, we established a mouse model suitable
to study mechanisms of interdependence between heart fail-
ure and its consequences on nervous system functioning. With
this experimental setup, we tested the hypothesis whether exper-
imental CHF after myocardial infarction leads to depression-
and anxiety-like behavior due to structural and functional brain
changes.
MATERIALS AND METHODS
ANIMALS
Male C57BL/6N mice (6–9 weeks of age) were obtained from
Charles River (Sulzfeld, Germany) and were maintained at ambi-
ent temperature (21.5 ± 0.5◦C) and humidity (50 ± 5%) under
a 14/10 h light/dark cycle (lights on at 07:00 h) with food and
water ad libitum. Mice were housed in groups of 4–6 per cage
and allowed to habituate to the housing facility for at least 1
week before being subjected to MI or sham operation. Animals
were housed individually following surgery and the first echocar-
diography. All animal protocols observed the provisions of the
Animal Protection Law according to the Directive of the European
Communities Council of 1986 (86/609/EEC), and have been
reviewed and approved by the review board of the District
Government of Lower Franconia and the University ofWürzburg.
PROTOCOL
Cardiac operation was initially performed. Starting 4 days after
the surgery, mice were tested for anhedonic behavior once per
week over a period of 8 weeks using the SPT. 6 weeks after the
operation, mice were subjected to a behavioral test battery (in
that order: EPM, LDB, OF, OR) to assess exploratory activity,
anxiety-like behavior and short-term object recognition memory.
The same mice underwent all behavioral tests. All experiments
were performed during the light phase between 10:00 and 15:00,
with an intertest-interval of 48 h. Echocardiography was per-
formed 1 day, 3 and 8 weeks after surgery. After completion of
the experiments, mice were sacrificed and hearts and brains were
removed for further analysis. The experimental design is depicted
in Figure 1.
MI AND SHAM OPERATION
MI vs. sham operation was induced in mice according to the
established protocol in our department (Hofmann et al., 2012). In
brief, mice were anaesthetized with isoflurane (about 2.0 vol.%),
intubated and put on a mechanical small animal ventilator. After
a left-sided thoracotomy, MI was induced by permanent ligating
the proximal portion of the left anterior descending (LAD) coro-
nary artery. Buprenorphin (0.002mg per mouse) was given i.p.
for analgesia perioperatively. In parallel subgroups, thoracotomy
FIGURE 1 | Experimental design. LAD, left anterior descending coronary artery; d, day; w, week.
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was performed to expose the heart but no suture was made to the
coronary artery (sham operation).
ECHOCARDIOGRAPHIC ANALYSIS
Echocardiography was performed and evaluated as previously
described (Hofmann et al., 2012). Serial ultrasound analyses
were performed on a Toshiba Apliosystem with a 15-MHz ultra-
sound probe under light anesthesia with isoflurane (about 1.5
vol.%) and spontaneous respiration by a single researcher experi-
enced in rodent echocardiography blinded to the type of oper-
ation. From two-dimensional short axis imaging, endocardial
borders were traced at end-systole and end-diastole utilizing
a prototype off-line analysis system (NICE, Toshiba Medical
Systems, The Netherlands). Measurements were performed at
the mid-papillary muscle level. The end-systolic (smallest) and
end-diastolic (largest) cavity areas were determined. Using the
end-systolic and -diastolic areas, fractional area changes were
calculated [(end-diastolic area—end-systolic area)/end-diastolic
area]. From two-dimensionally targeted M-mode tracings, end-
diastolic diameter and end-systolic diameter were measured.
Fractional shortening was calculated. Only mice with a heart rate
greater than 450/min were included in the analysis.
SUCROSE PREFERENCE TEST
Mice were given concurrent access to one bottle of 1% (w/v)
sucrose solution and one bottle of tap water for 48 h per week.
The bottles were weighed after 24 h and their positions switched
in order to minimize possible effects of side-preference. Sucrose
preference was calculated as the percentage of sucrose solution
consumed relative to total liquid intake, with a reduced sucrose
preference being an indicator of anhedonic behavior.
ELEVATED PLUS MAZE
The EPM was made from black perspex (TSE Systems), semiper-
meable for infrared light, and illuminated by infrared LEDs from
below (Post et al., 2011). The apparatus was elevated to a height
of 60 cm above floor level and comprised two opposing open
arms (30 × 5 × 0.25 cm, 30lx) and two opposing closed arms
(30 × 5 × 15 cm, 5lx) extending from a central platform (5 ×
5 cm, 15lx). Mice were placed in the center, facing an open arm,
and their behavior was recorded for 10min using the VideoMot2
system (TSE Systems, Bad Homburg, Germany). Behavioral mea-
sures included total distance traveled, time spent moving, vertical
rears, number of entries, and time spent in each zone of the
maze, frequency and duration of grooming bouts and defeca-
tion/urination.
LIGHT-DARK BOX
The LDB comprised a transparent, brightly illuminated’lit’ com-
partment (40 × 40 × 27 cm, 300lx) and a small enclosed “dark”
compartment (40 × 20 × 27 cm, 0–5lx) with a central gate (5 ×
5 cm) (Bourin and Hascoet, 2003). Mice were placed into the
dark compartment and their behavior was recorded for 10min.
Behavioral measures included the latency and time mice spent
head-poking into the lit compartment, the latency and time mice
spent in the lit compartment and defecation/urination.
OPEN FIELD
The OF consisted of a gray opaque PVC box (82 × 82 × 25 cm),
divided into a 52 × 52 cm center zone (100lx) and the surround-
ing periphery (50lx). Mice were placed in the periphery and
their behavior was recorded for 10min using the VideoMot2
system (TSE Systems, Bad Homburg, Germany) (Post et al.,
2011). Variables measured included total distance traveled, time
spent moving, vertical rears, number of entries, and time spent
in the center, frequency, and duration of grooming bouts and
defecation/urination.
OBJECT RECOGNITION
The test was performed 24 h after the OF in the same testing
arena, i.e., the OF test served as habituation phase. During train-
ing (familiarization phase), mice explored two identical objects
(A1 and A2) for 10min. After a 1 h-retention interval, mice were
allowed to explore one familiar (A2) and one novel (B) object for
10min. The novel object location was counterbalanced between
groups to avoid potential effects of side-preference. The discrim-
ination index (%) was calculated as ratio of the time mice spent
exploring one of the two objects during training (A1) or the novel
object in the test phase (B) over the total time exploring both
objects, i.e., A1/(A1 + A2)× 100 (training) and B/(B+A2)× 100
(retention test). Thus, an index>50% indicates novel object pref-
erence, <50% familiar object preference, and 50% no preference
(Hammond et al., 2004).
SAMPLE COLLECTION, DETERMINATION OF INFARCT SIZE,
VENTRICULAR REMODELING, AND QUANTIFICATION OF HEART
FAILURE
After completion of the experiments, animals were anes-
thetized with a lethal dose of 0.25% tribromoethanol (Avertin)
(0.125mg/g, i.p.). The brains were removed and snap frozen
in isopentane. The organs were weighed and stored in paraffin
or liquid nitrogen. The left ventricle was cut into three trans-
verse sections: apex, middle ring and base as previously reported
(Hofmann et al., 2012). From the middle ring, 5μm-sections
were stained with picrosirius red. Infarct size (fraction of the
infarcted left ventricle) was calculated as the percentage of length
of circumference. Sham operated mice had no signs of myocar-
dial infarction. Animals with an infarct size of at least 30% were
attributed to the ischemic CHF group. In the correlation analysis
between the size of MI and behavioral features, all animals with a
quantifiable MI were included. From non-infarcted myocardium
α-MHC, β-MHC, ANP-1, SERT, 5HT2A, and 5HT2B mRNA was
quantified by real-time PCR. RNA isolation and real-time poly-
merase chain reaction procedures were performed with commer-
cially available RNA extraction kit and cDNA transcription kit
(Quiagen N.V.) and TaqMan probes (Applied biosystems, Foster
City) as reported previously (Hofmann et al., 2012). GAPDH was
used as the reference gene.
SEROTONIN ELISA
Serotonin values in serum and left ventricular myocardium were
assessed according to Uscn Serotonin ELISA E92890Mu (Uscn
Life Science, China). Protein was extracted out of serum and left
myocardial tissue. The total amount of protein in myocardium
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was measured with Qubit® Protein Assay (Invitrogen™|Life
Technologies, USA). Serotonin ELISA was performed according
to the protocol of Uscn Serotonin ELISA E92890Mu (Uscn Life
Science, China). To further compare the results, the values of
ELISA were referred to the amount of serum in ml or the amount
of protein in μg.
BRAIN HISTOLOGY AND IMMUNOHISTOCHEMISTRY
Whole mouse brains were cut into 18μm thick sagittal sections
on a cryostat (Leica, Wetzlar, Germany) and kept in −20◦C.
For immunohistochemistry, sections were fixed in 4%
paraformaldehyde (20min) and washed with PBS 3 times. For
peroxidase labeling, sections were incubated with 3% hydrogen
peroxide in methanol for 20min to quench endogenous perox-
idases, permeabilized and blocked with 10% normal serum of
host species from which respective secondary antibodies were
derived for 1 h at room temperature. Sections were incubated
with mouse anti-NeuN (1:500, Millipore, Schwalbach, Germany),
mouse anti-MAP2 (1:500, Millipore, Schwalbach, Germany),
mouse anti-GFAP (1:1000, Novocastra, Berlin, Germany), rabbit
anti-nestin (1:500, BD Pharmingen, Heidelberg, Germany), goat
anti-doublecortin (1:500, C-18, Santa Cruz Biotech, Santa Cruz,
CA, USA), mouse anti-beta-tubulin III (1:200, Sigma-Aldrich,
Taufkirchen, Germany), rabbit anti-Pax6 (1:200, Millipore,
Schwalbach, Germany), rat anti mouse MAC-1 (CD11b, 1:50,
Serotec, Düsseldorf, Germany), mouse non-phosphorylated neu-
rofilament (anti-SMI32, 1:1000, Covance, Munich, Germany),
or rabbit anti cleaved caspase-3 (1:500, New England Biolabs,
Frankfurt am Main, Germany) antibodies respectively diluted
in 3% normal serum, 0.5% Triton-X in PBS for 24 h at
4◦C. After 3 washes with PBS, sections were incubated with
biotinylated secondary antibodies for 1 h and the staining was
visualized by a peroxidase-labeled avidin-biotin kit (Vector
Laboratories, Burlingame, CA, USA). The sections were allowed
to dry overnight and mounted using DePeX (Serva, Heidelberg,
Germany).
For Nissl staining, sections were immersed for 25min in a
dilute cresyl violet stain (0.01%) in acetate buffer (pH 4.5). After
being dehydrated in serial dilutions of ethyl alcohol, sections were
mounted using DePeX (Byts et al., 2008).
RNA SEQUENCING IN BRAIN TISSUE
RNA sequencing analysis was performed in two brain regions
(prefrontal cortex, and hippocampus) and left ventricular
myocardium. Total RNA was extracted according to the Direct-
Zol RNA Miniprep kit (Zymo Research Corporation, Irvine).
RNA of 3 CHF mice vs. 6 sham operated mice was pooled and
further subjected to RNA sequencing. To fabricate singular
pools each probe of the group equally contributed with the final
amount of 2μg RNA per pool with the result that we had 6
different pools to be further evaluated. The RNA sequencing was
performed by IGA Technology, Italy (http://www.igatechnology.
com/). RNA samples were processed using TruSeq Stranded
Total RNA with Ribo-Zero Human/Mouse/Rat from Illumina
(Illumina, Inc., CA, USA). Briefly, the total RNA was treated
with Ribo-Zero to remove cytoplasmic rRNA, fragmented into
small pieces using divalent cations under elevated temperature,
cDNA was synthesized by reverse transcription and standard
blunt-ending plus add “A” was performed. Then, Illumina
TruSeq adapters with indexes were ligated to the ends of the
cDNA fragments. After ligation reaction and separation of not
ligated adapters, samples were amplified by PCR to selectively
enrich those cDNA fragments in the library having adapter
molecules at both ends. A pool of the 4 samples was loaded on
two lane of Illumina flowcell and clusters created by Illumina
cBot. The clusters were sequenced at ultra-high throughput on
the Illumina HiSeq2000 (Illumina Inc.). Two lanes in 4-plex were
run obtaining about 50 millions of single-reads per sample, 50
bp long. CLC-Bio Genomics Workbench software (CLC Bio,
Denmark) was used to calculate gene expression levels based
on Mortazavi et al. approach. The sensitivity of RNA-Seq is a
function of both molar concentration and transcript length.
We therefore quantified transcript levels in reads per kilobase
of exon model per million mapped reads (RPKM). The RPKM
measure of read density reflects the molar concentration of
a transcript in the starting sample by normalizing for RNA
length and for the total read number in the measurement. This
facilitates transparent comparison of transcript levels both within
and between samples. The reference genome used to align the
reads was GRCm38 downloaded at the following ftp address:
ftp://ftp.ncbi.nlm.nih.gov/genbank/genomes/Eukaryotes/vertebra
tes_mammals/Mus_musculus/GRCm38.p1/Primary_Assembly/as
sembled_chromosomes/FASTA/.
Only genes with the number of at least 100 unique gene reads
were considered for data analysis. Comparisons within the groups
were based on the ratio of RPKM values of each singular gene and
were performed logarithmically (Mortazavi et al., 2008). Relevant
up- or down-regulation of gene expression was defined as a log2
fold-change (logarithmized ratio of RPKM in CHF over RPKM
in sham-operated mice) of ≥0.9 or ≤−0.9, which means ≥1.86
fold decrease or increase, in CHF mice over sham-operated
animals.
STATISTICAL ANALYSIS
Statistical analyses were performed using IBM SPSS Statistics 19
(IBM, Armonk, New York) or StatView 5.0 (Abacus Concepts,
Berkley, CA, USA). Differences between groups (CHF vs. sham)
were analyzed using unpaired t-tests. In addition, paired t-tests
were performed within each group to assess habituation in the
object recognition test (training vs. retention test). Data obtained
from the sucrose preference test were analyzed via Two-Way
mixed ANOVA with group as between-subjects factor and time as
repeatedmeasures factor, followed by planned contrasts to further
analyse significant main effects of time or time x group interac-
tions. Correlations betweenMI size and behavioral measures were
analyzed using Pearson’s correlation (one-tailed); all animals with
a quantifiable MI were included in these analyses. A probability
of p < 0.05 was considered statistically significant. All results are
expressed as mean ± s.e.m.
RESULTS
COHORT DESCRIPTION
13 CHF mice with MI size ≥30% (50.2 ± 2.8%) and 16 mice
with sham operation were included in the analysis (Table 1). For
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Table 1 | Infarct size, organ and body weights 8 weeks after surgery in
CHF vs. sham mice.
CHF after MI Sham
Infarct size, % 50±2.8 0
RV weight/BW weight, mg/g 1.07±0.05** 0.86±0.03
LV weight/BW weight, mg/g 4.87±0.21** 3.44±0.09
Lung weight/BW weight, mg/g 6.28±0.33 5.55±0.23
Body weight, g 28.5±0.3 28.4±0.5
Mean ± s.e.m. RV, right ventricle; LV, left ventricle; BW, body weight. (*p < 0.05,
**p < 0.01, CHF vs. Sham).
correlation analysis, data of all mice with measurable infarct size
(n = 19;MI = 37.7 ± 4.0%) were included.
Echocardiography showed upon ligation of the LAD wall
motion abnormalities of the left chamber, reduced fraction short-
ening (p < 0.001), and left ventricular chamber dilation (p <
0.001) (Table 2) in line with heart failure. No histological and
echocardiographic changes typical for MI were observed in the
sham group (Supplementary Figure 1). The relative weight of
the right ventricle (p = 0.002) and the left ventricle (p < 0.001)
was increased in mice with ischemic CHF (Table 1). Additionally,
markers of heart failure were increased (β-MHC [763 ± 32 vs.
27 ± 14 arb. units; p = 0.001]; ANP-1 [886 ± 475 vs. 359 ±
556 arb. units; p = 0.006]) or decreased (α-MHC [1230 ± 320
vs. 1670 ± 260 arb. units; p = 0.0099]) on the RNA-level in
mice with myocardial infarction as expected (Van Rooij et al.,
2007; Ghosh and Haddad, 2011). Further relevant changes of
inflammatory cytokines (e.g., 2-fold increase of TGF-β1, 3-fold
increase of IL10 receptor, 2-fold decrease of IL15) were found in
myocardial tissue of CHF mice in RNA-sequencing analysis.
SUCROSE PREFERENCE TEST
Total liquid intake
Repeated-measures ANOVA found a significant time x group
interaction for total liquid intake (p = 0.034; Figure 2A).
Follow-up comparisons revealed that liquid consumption was
significantly decreased in CHF mice during the first 2 weeks
post-surgery (p < 0.01), whereas no differences between CHF
and sham mice were observed between 3 and 8 weeks after the
operation.
Water intake
Repeated-measures ANOVA indicated that water intake did not
change in both groups over the 8-week testing period. However,
on average, CHF mice consumed more water than sham controls
(p = 0.051; Supplementary Table 1).
Sucrose intake
Repeated-measures ANOVA revealed that sucrose intake changed
significantly in both groups over the 8-week testing period (time
effect: p < 0.001). Repeated contrasts indicated an increase in
sucrose consumption during the first 3 weeks post-surgery and
a drop in sucrose intake in the last testing session compared to
the preceding one. On average, CHF mice consumed less sucrose
than sham controls (p = 0.029; Supplementary Table 1).
Table 2 | Echocardiographic measurements 1 day and 8 weeks after
surgery in CHF vs. sham mice.
1 day 8 weeks
CHF after MI Sham CHF after MI Sham
ESA [mm2] 8.87±0.57** 5.75±0.72 21.69±2.24** 4.96±0.61
EDA [mm2] 10.74±0.57* 8.39±0.68 24.36±2.18** 7.54±0.6
2D FS [%] 18±2** 34±3 13±2** 36±3
ESD [cm] 0.35±0.02** 0.26±0.01 0.57±0.04** 0.27±0.01
EDD [cm] 0.40±0.02 0.36±0.01 0.62±0.03** 0.36±0.01
FS [%] 11±1** 28±2 8±1** 25±2
HR [1/min] 488±15 552±15 548±23 578±15
Mean ± s.e.m. EDA, end-diastolic area; ESA, end-systolic area; FS, fractional
shortening; 2D, two-dimensional; ESD, end-systolic diameter; EDD, end-diastolic
diameter; HR, heart rate. (*p < 0.05, **p < 0.01, CHF vs. sham).
FIGURE 2 | Sucrose preference test. (A) Total liquid intake was
significantly decreased in CHF mice during the first 2 weeks after surgery,
whereas no differences were observed between 3 and 8 weeks after the
operation. (B) The average preference for sucrose was significantly
diminished in CHF mice (n = 13) compared to sham controls (n = 16).
Averaged total liquid intake (C) and sucrose preference (D) were negatively
correlated with MI size (n = 19). Mean ± s.e.m. ∗p < 0.05.
Sucrose preference
Repeated-measures ANOVA found a significant effect of time
for sucrose preference (p < 0.01; Figure 2B). Follow-up compar-
isons revealed that sucrose preference was significantly decreased
in both groups during the first week post-surgery compared to
all other points in time (all p < 0.05). Moreover, the average
preference for sucrose was significantly diminished in CHF mice
compared to sham controls (p = 0.029; Supplementary Table 1).
Correlation
Pearson’s correlation coefficients (Supplementary Table 1)
revealed a significant negative relation between MI size and
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the averaged total liquid intake (p = 0.033; Figure 2C), the
sucrose intake (p = 0.022) and the sucrose preference (p = 0.049;
Figure 2D).
ELEVATED PLUS MAZE
The time spent moving (Figure 3A), the distance traveled and
the relative velocity did not differ between CHF and sham
mice. However, CHF mice made significantly less vertical rears
(p = 0.033; Figure 3B) and spent more time in the center of
the EPM (p = 0.024; Figure 3C) than sham controls. However,
there were no significant differences between groups regarding
anxiety-related measures, including the number of entries and
time spent on the open arms (Figure 3D), as well as defeca-
tion/urination (Supplementary Table 2). Pearson’s correlation
coefficients (Supplementary Table 2) revealed no significant rela-
tions between MI size and any of the variables measured in the
EPM (Figures 3E–H).
LIGHT-DARK BOX
There was neither a significant difference between CHF and sham
mice regarding latency and time mice spent head-poking from
the dark into the lit compartment nor latency and time mice
spent exploring the lit compartment (Figures, 4A–D), nor in the
defecation/urination index (Supplementary Table 3). Pearson’s
correlation coefficients (Supplementary Table 3) revealed a sig-
nificant negative relation between MI size and head-poking fre-
quency (p = 0.029) as well as head-poking duration (p = 0.029;
Figure 4F). No correlations were found for MI size and head-
poking latency (Figure 4E), latency to enter (Figure 4G) and time
spent in the lit compartment (Figure 4H).
OPEN FIELD
CHF mice spent significantly less time moving (p = 0.016;
Figure 5A) and traveled shorter distances (p = 0.021) than sham
controls. Moreover, CHF mice displayed a prolonged latency to
rear (p = 0.009) and tended to make less vertical rears (p =
0.064; Figure 5B) as compared to sham controls. However, the
relative velocity and anxiety-related measures, including the
number of entries and time spent in the center (Figure 5C),as
well as defecation/urination (Supplementary Table 4) did not dif-
fer between CHF and sham mice. Moreover, CHF mice showed
an increased number (p = 0.022; Figure 5D) and cumulative
duration of grooming bouts (p = 0.028). Pearson’s correlation
coefficients (Supplementary Table 4) revealed a significant neg-
ative relation between MI size and time spent moving (p =
0.037; Figure 5E). However, no correlation was found for MI
size and number of rears, center time and grooming frequency
(Figures 5F–H).
OBJECT RECOGNITION
CHFmice spent less timemoving than sham controls in the train-
ing trial (p = 0.046), but not in the retention test (Figure 6A).
Despite reduced locomotion in CHF mice, the relative velocity
did not differ between groups during training. However, CHF
mice moved faster than sham controls in the retention test (p =
0.035; Supplementary Table 5A). Moreover, the total duration of
object exploration did not differ between CHF and sham mice
in the training trial, but tended to be decreased in sham mice
in the retention test (p = 0.071; Figure 6B). During training,
both groups showed similar preferences for the two identical
objects. In the retention test, however, CHF mice exhibited a
FIGURE 3 | Elevated plus maze. (A) Time spent moving did not differ
between the groups, although CHF mice (n = 13) made significantly less
vertical rears (B) and spent more time in the center (C) than sham controls
(n = 16). However, time spent on the open arms (D) did not differ. (E–H)
None of the behavioral measures were correlated with MI size (n = 19).
Mean ± s.e.m. ∗p < 0.05.
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FIGURE 4 | Light-dark box. Neither (A) head-poking latency and (B)
head-poking duration nor (C) latency and (D) time spent in the lit
compartment differed between CHF (n = 13) and sham mice (n = 16).
(E) Head-poking latency was not correlated with MI size (n = 19).
However, there was a relation between MI size and (F) head-poking
duration. (G) Latency to enter the lit compartment and (H) time spent in
the lit compartment were not associated with MI size. Mean ± s.e.m.
∗p < 0.05.
FIGURE 5 | Open field. (A) Time spent moving and (B) number of rears were
significantly decreased in CHF mice, although (C) time spent in the center did
not differ between the groups. (D) Number of grooming bouts was
significantly increased in CHF mice (n = 13) compared to sham controls
(n = 16). (E) Time spent moving was negatively correlated with MI size
(n = 19), whereas (F) number of rears, (G) center time and (H) grooming
frequency were not associated with MI size. Mean ± s.e.m. #p < 0.1,
∗p < 0.05.
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significantly decreased discrimination index as compared to sham
controls (p = 0.022; Figure 6C), reflecting a reduced preference
for the novel object. Moreover, paired t-tests (Supplementary
Table 5B) comparing training and retention test revealed a sig-
nificant decrease in the distance traveled (p < 0.001), time spent
moving (p < 0.001; Figure 6A), relative velocity (p = 0.002),
total object exploration time (p = 0.008; Figure 6B) and total
number of visits (p = 0.020) in sham mice. However, none of
these measures reached significance in CHF mice, indicating dif-
ferences between groups in habituating to the objects and the
environment. Pearson’s correlation coefficients (Supplementary
Table 5A) revealed a significant negative correlation between MI
size and time spent moving (training: p = 0.049; retention test:
p = 0.047; Figure 6D). However, no correlation was found forMI
size and total exploration time as well as the discrimination index
in the retention test (Figures 6E,F).
SEROTONIN PATHWAY IN FAILING LEFT MYOCARDIUM
Serum values of serotonin did not differ between CHF and sham-
operated animals (227 ± 26 vs. 216 ± 34 ng/ml; p = 0.37), but
production of serotonin was elevated in the left myocardium
of CHF mice compared to sham controls (0.051 ± 0.022 vs.
0.034 ± 0.009 ng/10μg protein; p = 0.042). Additionally, we
found increased expression of the serotonin receptor 5HT2B in
the failing left myocardial tissue (127 ± 50 vs. 82 ± 42 arb. units;
p = 0.012) without differences in expression of serotonin trans-
porter (171± 106 vs. 110± 55 arb. units; p = 0.15) and serotonin
receptor 5HT2A (296 ± 125 vs. 349 ± 140 arb. units; p = 0.44).
BRAIN HISTOLOGY AND IMMUNOHISTOCHEMISTRY
Histological analysis of the brains 8 weeks after MI in 5 mice with
CHF and 5 sham-operated control mice showed normal general
brain morphology in all animals regardless of the extent of the
myocardial damage. Immunohistochemical analysis (Figure 7)
showed normal expression pattern of markers for neurons (MAP-
2, NeuN) and astrocytes (GFAP). Analysis of the brains using
markers for neurogenesis (nestin, Pax-6, doublecortin, beta-
Tubulin-III) showed no differences between the groups. Staining
for markers of inflammation (MAC-1), neurodegeneration (SMI-
32), or apoptosis (cleaved caspase 3) were negative in both
groups.
RNA SEQUENCING
Analysis of gene expression by means of RNA sequencing in
prefrontal cortex and hippocampus revealed that 25 confidently
detected mRNAs were up- or down-regulated, defined as a log2
fold-change of ≥0.9 or ≤−0.9, which means ≥1.86 fold decrease
or increase in CHF mice over sham-operated animals (Figure 8,
Supplementary Table 6). A subset of regulated genes of interest
was confirmed by RT-PCR to further verify our results of RNA-
sequencing analysis. 1182 genes were regulated in the left ven-
tricular myocardium after development of CHF after MI. Nr4a1
was the only gene regulated both in left ventricular tissue (5-fold
increase) and in the prefrontal cortex (almost 2-fold decrease) of
CHFmice. Further gene regulation of the CHFmyocardium is not
the main topic of this manuscript and is therefore not presented
in detail.
FIGURE 6 | Object recognition. (A) CHF mice (n = 11) spent less time
moving than sham controls (n = 14) in the training trial, but not in the
retention test. (B) The total duration of object exploration did not differ
between CHF and sham mice during training, but tended to be decreased in
sham mice in the retention test. (C) The discrimination index for a novel
object was significantly decreased in CHF mice in the retention test. (D)
Time spent moving in the retention test was negatively correlated with MI
size (n = 16). There was no correlation between MI size and (E) total
exploration time as well as (F) discrimination index. Mean ± s.e.m. #p < 0.1,
∗p < 0.05, ∗∗p < 0.01.
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FIGURE 7 | Histological brain analysis. Representative
immunohistochemical staining without differences for neuronal (A,B NeuN,
C-D MAP-2), astrocytic (E,F GFAP) and neural stem cell (G,H nestin)
markers in dorsal hippocampus of a sham mouse (A,C,E,G) and a CHF
mouse (B,D,F,H). Insets in (G,H) show high power field of nestin-positive
cells (arrow) in the granule cell layer of gyrus dentatus. Scale bar = 100μm.
DISCUSSION
Taken together, our study shows that experimental CHF in
mice induced depression-like behavior indicated by a persis-
tent anhedonic-like state, reduced motivation and preference for
novelty as well as impaired cognitive abilities.
DEPRESSION AND ANHEDONIA IN CHF
Anhedonia is a state of decreased ability to experience pleasures or
rewards and is a core symptom of clinical depression. In rodents,
a decrease in sucrose preference can be regarded as a primary fea-
ture of anhedonia, suggesting a depression-like state (Strekalova
et al., 2004). Previous studies have shown that acute MI in rats
induces anhedonia (Wann et al., 2007, 2009; Bah et al., 2011).
Our findings show a persistent anhedonic state in mice with CHF.
Lack of differences in body weight between the groups excludes
possible metabolic confounders contributing to different sucrose
intake. Moreover, sucrose preference was negatively correlated
with infarct size, suggesting that severity of the hedonic deficit
was associated with the degree of cardiac dysfunction. Despair
FIGURE 8 | mRNA sequencing in the brain. Comparison of mRNA
expression in (A) prefrontal cortex and (B) hippocampus of CHF (n = 3) and
sham (n = 6) mice.
is also a major symptom of clinical depression. However, we did
not perform the forced swim test to assess behavioral despair in
anticipation of increased mortality in CHF mice subsequent to
the test-induced stressful experience and based on the inherent
limitation that the forced swim test was originally designed to test
antidepressant drug efficacy.
ANXIETY-LIKE BEHAVIOR IN CHF
To assess anxiety-like behavior and other features of depression-
like behavior, such as interest in novelty, exploratory behavior, as
well as general locomotor activity, mice were tested in the elevated
plus maze, the light-dark box and the open field. The avoidance
of the aversive areas and preference of the more protected zones
of the respective arenas were similar in both groups in all three
tests.
While measures suggestive of anxiety-like behavior were not
affected by CHF, CHFmice exhibited both a decreased locomotor
activity and a lack of motivation to explore a novel environment.
However, EPM, LDB, and OF tests explicitly depend on intact
sensory and motor functions. Thus, abnormalities in locomo-
tor activity may confound the results, especially when analyzing
conventional spatiotemporal measures such as latency to enter,
number of entries and time spent in the aversive area (Cryan
and Holmes, 2005). We assessed additional parameters such as
rearing, grooming, freezing, head dipping, stretching, defecation
and urination to control for these confounders. In the present
study, locomotor activity was significantly reduced in CHF mice
in the OF, but not in the EPM, whereas vertical rearing activ-
ity was significantly affected in both tests. However, the relative
velocity did not differ between CHF and sham mice in both EPM
and OF, suggesting that CHF did not cause grave physical dis-
abilities. The analysis of vegetative behaviors, as measured by
defecation and urination (a conventional emotionality index) in
the EPM, LDB, and OF, did not reveal a significant difference
between CHF mice and sham controls. Taken together, our data
indicate that the reduced exploratory behavior observed in CHF
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mice wasmost likely due to a lack of motivation and reduced pref-
erence for novelty rather than an anxiety-induced suppression of
exploration.
Grooming behavior is an established marker of stress in
rodents, including stress-coping and de-arousal (Kalueff and
Tuohimaa, 2005). However, rodent’s self-grooming can be
increased by both stress and comfort conditions (Kalueff and
Tuohimaa, 2004). Since exposure to a novel environment induces
mild to moderate levels of stress, the grooming behavior observed
in our tests can be considered as stress-evoked “displacement”
grooming, which is different from low-stress grooming and
characterized by frequent and rapid short bursts (Kalueff and
Tuohimaa, 2005). Analysis of grooming behavior revealed a sig-
nificant increase in the number and duration of grooming bouts
in CHF mice in the OF, but not in the EPM, suggesting that CHF
induced deficits in stress-coping depending on the type of test.
COGNITIVE IMPAIRMENT IN CHF
To assess non-spatial learning and memory, mice were tested
in the OR test, which is based on the spontaneous tendency of
rodents to explore a novel object over a familiar one (Ennaceur
and Delacour, 1988). Using a 1 h retention interval between train-
ing and testing phase, we could show that CHF mice display
less habituation to the testing environment and a significantly
decreased ability to discriminate between a novel and a famil-
iar object. Thus, CHF induced deficits in short-term recognition
memory, which is found in patients with depressive disorder
(Kindermann et al., 2012).
MECHANISTIC CONSIDERATIONS
Elevation of serotonin, being associated with depression, platelet
activation and increased cardiovascular risk (Williams, 2012), was
found in myocardial tissue, accompanied by increased expression
of 5HT2B (one of serotonin receptors), which suggests serotonin
system to be involved in remodeling processes during develop-
ment of CHF. However, other pathways than serotonin system
could also be of mechanistic importance to understand the inter-
relation between the brain and the failing heart: Several brain
regions are activated in rats after MI and in CHF patients as for
example the hypothalamic paraventricular nucleus (Han et al.,
2010; Rana et al., 2010; Almeida et al., 2012). Visual examina-
tion of brain MRI can detect damage in patients with CHF in
areas regulating depression and executive function, including the
right hippocampus and left frontal cortex (Pan et al., 2013). Even
though we could not find general structural changes in brains of
mice after MI, we could detect differences of RNA expression of
several hippocampal and prefrontal cortical genes—both brain
regions, whose structural and functional alterations are associated
with an increased risk for developing major depressive disorder
(Spinelli et al., 2013).
Gene expression in the hippocampus
Hypoxia-inducible factors (HIFs) are key mediators of cellular
adaptation to hypoxia, but also respond to non-hypoxic stimuli. It
is thought that factors containing the alpha-3 subunit are negative
regulators of hypoxia-inducible gene expression (Makino et al.,
2001). Transcriptional up-regulation of HIF-3alpha as found in
CHF mice in hippocampus may therefore represent a typical
response to in vivo hypoxia, hypoglycaemia, and glucoprivation
in the brain after MI and CHF development (Heidbreder et al.,
2007).
The nuclear receptor Retinoid-related orphan receptor-alpha
(RORA), which is up-regulated in hippocampus of CHF mice,
exerts a bi-directional regulation of astrocytes, being neuro-
protective and anti-inflammatory, a pluripotent molecular player
in constitutive and adaptive astrocyte physiology as adaptation
after CHF development (Journiac et al., 2009). Additionally,
several genetic studies have found an association between vari-
ations of RORA and pro-depressive behavior in humans (Utge
et al., 2010), which fits to RORA up-regulation in mice with
pro-depressive behavior due to CHF.
Furthermore, there seem to be changes in axonal vesicular
transport with subsequent maintenance of presynaptic function
and regulation of synaptic plasticity and synaptic transmission
in hippocampus after CHF induction as far as we found down-
regulation in gene expression of Kif5b, responsible for axonal
vesicular transport, and Gabrb2, responsible for regulation of
synaptic transmission (Ma et al., 2009). Corresponding to our
findings Gabrb2 was found to be decreased in the brain in mood
disorders (Zhao et al., 2012).
Gene expression in the prefrontal cortex
Furthermore, gene expression in the prefrontal cortex revealed a
few regulated genes after MI. We found diminished expression
of Npas4, Arc, Junb, and Nr4a1 in CHF. Npas4 has been impli-
cated in the formation and maintenance of inhibitory synapses
(Shamloo et al., 2006) and it is transcribed in response to exci-
tatory synaptic activity (Lin et al., 2008). Actual findings suggest
that Npas4 participates in the regulation of the balance between
neuronal excitation and inhibition by contributing to the mainte-
nance of the inhibitory pathways (Coutellier et al., 2012). Relative
hippocampal Npas4 expression was significantly lower in a rat
depression model compared to controls (Zhang et al., 2014).
Activity-regulated cytoskeleton-associated protein (Arc, also
known as Arg3.1) is a plasticity protein which is believed to play
a critical role in learning and memory-related molecular pro-
cesses (McIntyre et al., 2005). Arc is widely considered to be an
important protein in neurobiology because of its activity regula-
tion, localization, and utility as a marker for plastic changes in the
brain (Kang et al., 2008). CHF is known to be associated not only
with depression but also with cognitive impairment in humans
(Angermann et al., 2012; Huijts et al., 2013), thus Arc could be a
potential link between CHF and cognition.
Junb as a protooncogen has additional function in behavioral
changes and was found to be up-regulated in depression (Orsetti
et al., 2009). We found decreased Junb levels in CHF mice with
depression-like behavior, with the result that function of Junb
cannot be finally established in depression.
Nr4a1 (also, so-called NGFIB) protein is involved in cell
cycle mediation, inflammation and apoptosis and is expressed
in macrophages and plays a key role in mediating inflamma-
tory responses (Pei et al., 2006). Nr4a1 is the only gene which
was regulated both in the brain and in the heart: almost 2-fold
decreased in the prefrontal cortex and 5-fold increased in left
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ventricular myocardium of mice with CHF, which is not surpris-
ing as far as macrophages are well known to play a relevant role
in remodeling after myocardial infarction (Hamid et al., 2009;
Ismahil et al., 2013).
In summary, we can conclude that we did not find histologi-
cal, structural changes in the brain of CHF mice, but we found
relevant changes in the expression of genes responsible for axonal
vesicle transport (Kif5b), signal transduction (Arc, Gabrb2), lim-
itation of inflammation (RORA; Nr4a1) and of hypoxic brain
damage (Hif3a). Besides, the actual literature describes some of
the genes (RORA, Gabrb2, Npas4, and Junb) being associated
with depression-like behavior. Nr4a1 significantly regulated in
both brain and heart tissue after induction of ischemic CHF could
be a potential link and reveals the central role of inflammation in
the interrelation of the brain and the failing heart.
CLINICAL PERSPECTIVE
CHF in mice leads to depression- like behavior suggesting that
this interrelation is independent of human psychosocial stress.
The SADHART-CHF trial found that treatment with sertraline
compared with placebo did not provide greater reduction in
depression or improved cardiovascular status among patients
with HF and depression. However, patients were only treated with
sertraline for 12 weeks in this study, which might be a too short
time (O’connor et al., 2010). Further studies are on their way like
the MOOD-HF trial which addresses this question (Angermann
et al., 2007). The CHF mouse model may be used for further
mechanistic studies and developing therapeutic concepts beyond
antidepressants.
CONCLUSION
This study shows that experimental CHF in mice induces an
anhedonic-like state, which persists 8 weeks after the initial
insult. The hedonic deficit was accompanied by other features
of depression-like behavior, such as decreased exploratory activ-
ity, lessened interest in novelty and impaired stress-coping. The
behavioral changes inmice are comparable to symptoms observed
in humans with heart failure and comorbid depression. On the
molecular level we find evidence for changes in cerebral gene pro-
file related to inflammation and signal transduction. Thus, the
presentmodel of behavioral evaluation inmice with CHF afterMI
gives us new pathophysiologic insights of heart-brain interaction
during the process of heart failure development.
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